APA (7th ed.) Citation

Y, Y., E, P., R, A., P, G., L, N., I, H., . . . E, G. (2025). Response to ritlecitinib with or without narrow-band ultraviolet B add-on therapy in patients with active nonsegmental vitiligo: Results from a phase 2b extension study. Journal of the American Academy of Dermatology, 92(4), 781. https://doi.org/10.1016/j.jaad.2024.11.064

Chicago Style (17th ed.) Citation

Y, Yamaguchi, et al. "Response to Ritlecitinib with or Without Narrow-band Ultraviolet B Add-on Therapy in Patients with Active Nonsegmental Vitiligo: Results from a Phase 2b Extension Study." Journal of the American Academy of Dermatology 92, no. 4 (2025): 781. https://doi.org/10.1016/j.jaad.2024.11.064.

MLA (9th ed.) Citation

Y, Yamaguchi, et al. "Response to Ritlecitinib with or Without Narrow-band Ultraviolet B Add-on Therapy in Patients with Active Nonsegmental Vitiligo: Results from a Phase 2b Extension Study." Journal of the American Academy of Dermatology, vol. 92, no. 4, 2025, p. 781, https://doi.org/10.1016/j.jaad.2024.11.064.